| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 24, 2026 | ±3.1% | +3.3% | under-priced |
| October 23, 2025 | ±2.8% | +1.6% | over-priced |
| July 25, 2025 | ±3.2% | +1.4% | over-priced |
| April 28, 2025 | ±3.0% | -0.3% | over-priced |
| October 29, 2024 | ±2.0% | +0.7% | over-priced |
| August 6, 2024 | ±2.8% | +2.8% | over-priced |
| May 2, 2024 | ±2.4% | +0.3% | over-priced |
| November 3, 2023 | ±2.8% | +0.7% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $0.91 | $2.1B | $519M |
| Q4 FY2025 | $0.90 | $2.1B | $518M |
| Q3 FY2025 | $0.73 | $2.0B | $423M |
| Q2 FY2025 | $0.78 | $2.1B | $452M |
Nasdaq, Inc. Common Stock (NDAQ) reports in 85 days, with the next report estimated for September 6, 2026. Across the last 8 reports, options priced an average ±2.8% earnings move while the stock actually moved 1.4% on average — the market has systematically over-priced NDAQ's earnings risk. Fundamentals into the print: EPS up 33.8% year-over-year, revenue up 2.2%. QuantLogix's live 5-factor engine currently reads NDAQ as a buy at 56/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →